ライフサイエンスコーパス: standard medical therapy

1 rable quality of life compared to exhaustive standard medical therapy.

2 A, n = 23) or placebo (group B, n = 24) plus standard medical therapy.

3 itis (UC) was cost-effective compared to the standard medical therapy.

4 considerable morbidity and mortality despite standard medical therapy.

5 cranial hypertension that is unresponsive to standard medical therapy.

6 who have increased ICP that is resistant to standard medical therapy.

7 of symptomatic gastroparesis unresponsive to standard medical therapy.

8 ents with congestive heart failure receiving standard medical therapy.

9 two groups on the basis of their response to standard medical therapy.

10 scularization have refractory angina despite standard medical therapy.

11 or patients with gastroparesis refractory to standard medical therapy.

12 l health care strategies in conjunction with standard medical therapies.

13 atients were treated either with one or more standard medical therapies (72 patients) or with osteopa

14 ch use was not associated with choices about standard medical therapies after we controlled for clini

15 tic valve implantation (TAVI) is superior to standard medical therapy and noninferior to surgical aor

16 All patients also received standard medical therapy and were followed for 12 months

17 9 patients were randomly assigned to receive standard medical therapy, and 229 to receive standard me

18 e benefits from medications added to current standard medical therapy, and the harms of screening and

19 ies are being explored for IIH refractory to standard medical therapy, but their efficacy and safety

20 h severe, class IV heart failure who receive standard medical therapy exhibit a 1-year mortality rate

21 The standard medical therapy for symptomatic benign prostati

22 Adding an ACE inhibitor to standard medical therapy improves outcomes, including re

23 We sought to examine the use and impact of standard medical therapies in patients with end-stage re

24 UCS and AMT, as an adjuvant to standard medical therapy in acute chemical injury, are e

25 Trial of Intensified versus standard Medical therapy in Elderly patients with Conges

26 with lower in-hospital mortality rates than standard medical therapy in this Registry.

27 itored closely and treated aggressively with standard medical therapy, including diuretics, if they d

28 examined whether the addition of E. coli to standard medical therapy increased the chance of remissi

29 Standard medical therapy is highlighted and more recent

30 ed by abnormal muscle contractions for which standard medical therapy is often inadequate.

31 were randomly assigned to atorvastatin-based standard medical therapy or standard therapy plus STS in

32 standard medical therapy, and 229 to receive standard medical therapy plus a single-chamber ICD.

33 tonia that is not adequately controlled with standard medical therapy should be referred for consider

34 ed to groups given a combination of FPSA and standard medical therapy (SMT) (FPSA group, n = 77) or o

35 Patients were randomized to ECAD and standard medical therapy (SMT) or SMT alone.

36 Patients were randomized to receive standard medical therapy (STD) or STD plus an ICD.

37 ng early colectomy with IPAA strategy to the standard medical therapy strategy.

38 Our study demonstrates that on the basis of standard medical therapy, STS further reduce elevated hs

39 isease-specific management clinics join more standard medical therapies such as angiotensin convertin

40 All patients also received standard medical therapy together with a 1-week course o

41 adjusted life-years gained (QALY-gained) for standard medical therapy was 20.78, while QALY-gained fo

42 ion for acute decompensated HF refractory to standard medical therapy was associated with high incide

43 ients with stable coronary disease receiving standard medical therapy, we evaluated the pharmacokinet

44 compensated heart failure who were receiving standard medical therapy were randomly assigned to an ex

45 d had increased ICP that was unresponsive to standard medical therapy were studied.

46 entricular ejection fraction <36% to receive standard medical therapy with or without an ICD.

47 ospital to immediate transfer for PCI, or to standard medical therapy with transfer for rescue angiop